JOHN WILEY & SONS INC

• 

  Publisher Of

  • A step‐by‐step protocol for meiotic chromosome counts in flowering plants: A powerful and economical technique revisited.  Applications in Plant Sciences.  8. 2020
  • Motivation and Memory 2018
  • The Doomsday Equation and 50 years beyond: new perspectives on the human-water system.  Wiley Interdisciplinary Reviews: Water.  n/a-n/a. 2015
  • Exergy Analysis, Entropy Generation Minimization, and the Constructal Law 2015
  • Thermodynamics Fundamentals 2015
  • Phonon Studies 2012
  • siRNA applications in nanomedicine 2010
  • Diluted and undiluted vitreous cytology specimens have a similar cytodiagnostic yield.  Cancer.  111:433-433. 2007
  • Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies 2007
  • Impact of race on psychosocial characteristics of female bariatric surgery applicants.  The International Journal of Eating Disorders.  35:445-446. 2004
  • Convergence of a Galerkin method for 2-D discontinuous Euler flows.  Communications on Pure and Applied Mathematics.  53:786-798. 2000
  • Special issue: Symposium on density functional and applications (Part I of II) - Introduction.  International Journal of Quantum Chemistry.  69:227-227. 1998
  • COMPARISON OF REFERRING DIAGNOSES AND ELECTRODIAGNOSTIC FINDINGS IN AN ACADEMIC EMG LABORATORY.  Muscle & Nerve.  12:757-757. 1989
  • DECOMPOSITION OF CONCENTRIC NEEDLE EMG MOTOR UNIT ACTION-POTENTIALS.  Muscle & Nerve.  12:752-753. 1989
  • QUANTITATIVE EMG MYOTONIC-DYSTROPHY.  Muscle & Nerve.  12:761-761. 1989
  • RECORDING CHARACTERISTICS OF CONCENTRIC VS MONOPOLAR NEEDLE EMG ELECTRODES.  Muscle & Nerve.  12:756-756. 1989
  • RECORDING CHARACTERISTICS OF DISPOSABLE VERSUS REUSABLE CONCENTRIC EMG NEEDLE ELECTRODES.  Muscle & Nerve.  12:753-753. 1989
  • DIAGNOSTIC SENSITIVITY OF QUANTITATIVE MOTOR UNIT ACTION-POTENTIAL ANALYSIS.  Muscle & Nerve.  11:966-966. 1988
  • EMG STUDIES IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS RECEIVING THYROTROPIN-RELEASING-HORMONE.  Muscle & Nerve.  11:976-976. 1988
  • QUANTITATIVE EMG IN THE POSTPOLIO MUSCULAR-ATROPHY SYNDROME.  Muscle & Nerve.  11:959-959. 1988
  • SFEMG IN MYASTHENIA-GRAVIS - REPLY.  Muscle & Nerve.  10:837-837. 1987
  • A COMPUTER-BASED EMG REPORT-GENERATION AND DATABASE SYSTEM.  Muscle & Nerve.  10:669-669. 1987
  • COMPUTER-AIDED EMG FINDINGS IN INFLAMMATORY MYOPATHY.  Muscle & Nerve.  10:662-662. 1987
  • EPHAPTIC TRANSMISSION IN HEMIFACIAL SPASM - A SINGLE FIBER EMG STUDY.  Muscle & Nerve.  10:663-663. 1987
  • SERIAL QUANTITATIVE EMG STUDIES IN MOTOR-NEURON DISEASE.  Muscle & Nerve.  10:661-661. 1987
  • SINGLE FIBER ELECTROMYOGRAPHY IN MYASTHENIA-GRAVIS DURING PREGNANCY.  Muscle & Nerve.  10:667-667. 1987
  • AN AUTOMATED-METHOD OF MEASURING MOTOR UNIT ACTION-POTENTIAL FEATURES - FINDINGS IN NERVE AND MUSCLE DISEASES.  Muscle & Nerve.  9:667-667. 1986
  • THE EFFECT OF CHOLINESTERASE-INHIBITORS ON SINGLE-FIBER ELECTROMYOGRAPHY IN MYASTHENIA-GRAVIS.  Muscle & Nerve.  9:660-660. 1986
  • AUTOMATIC-ANALYSIS OF THE ELECTROMYOGRAPHIC INTERFERENCE PATTERN (ANALYSIS OF NUMBER OF SMALL TURNS, AMPLITUDE AND RECRUITMENT - ANSTAR).  Muscle & Nerve.  9:571-571. 1986
  • EFFECT OF TEMPERATURE ON NEUROMUSCULAR-TRANSMISSION.  Muscle & Nerve.  9:573-573. 1986
  • NEUROPHYSIOLOGIC MONITORING IN MYASTHENIA-GRAVIS.  Muscle & Nerve.  9:562-562. 1986
  • THE EFFECT OF FIRING RATE ON NEUROMUSCULAR JITTER.  Muscle & Nerve.  9:566-566. 1986
  • WHAT WE HAVE LEARNED ABOUT THE ABNORMAL MOTOR UNIT.  Muscle & Nerve.  9:83-83. 1986
  • AUTOMATIC-MEASUREMENT OF MOTOR UNIT ACTION-POTENTIAL DURATION.  Muscle & Nerve.  8:626-626. 1985
  • SINGLE FIBER ELECTROMYOGRAPHY IN CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA.  Muscle & Nerve.  8:624-624. 1985
  • THE DOUBLE-STEP TECHNIQUE OF REPETITIVE NERVE-STIMULATION.  Muscle & Nerve.  8:624-624. 1985
  • USE OF SINGLE FIBER ELECTROMYOGRAPHY TO PREDICT THE COURSE OF OCULAR MYASTHENIA.  Muscle & Nerve.  8:624-624. 1985
  • NUMBER OF TURNS IN THE EMG INTERFERENCE PATTERN MEASURED AT DIFFERENT FORCE LEVELS IN BICEPS.  Muscle & Nerve.  7:561-561. 1984
  • SIMULATION OF CONCENTRIC NEEDLE EMG MOTOR UNIT ACTION-POTENTIALS.  Muscle & Nerve.  7:562-562. 1984
  • THE MOTOR UNIT IN AMYOTROPHIC LATERAL SCLEROSIS - A MACRO EMG STUDY.  Muscle & Nerve.  5:556-556. 1982
  • Performability modelling techniques and tools 2001
  • Entropy generation through heat and fluid flow 1994
  • Entropy generation through heat and fluid flow 1982
  • Chapter 24, (MulticriteriaAnalysis). 2011
  • Software Aging and Rejuvenation 2007
  • Skin graft reconstruction of the composite resection defect - Comment.  Head & Neck.  18:543-544. 1996
  • Beta-hydroxybutyrate and niacin protect the murine liver from acute inflammatory injury via activation of the Gpr109 receptor.  Hepatology (Baltimore, Md.).  Volume 60:501-509.
  • Recurrent and De Novo Autoimmune Hepatitis: A Comparison of Prevalence, Patient Characteristics and Outcomes at a Single Center.  Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. S110-S111. 2010
  • GENDER AND HORMONAL STATUS ARE ASSOCIATED WITH SEVERITY OF HISTOLOGIC FEATURES AMONG PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE.  Hepatology (Baltimore, Md.). 772A-773A. 2009
  • HEDGEHOG SIGNALING, STELLATE CELL/ENDOTHELIAL CELL CROSS-TALK AND PROGRESSION OF VIRAL HEPATITIS.  Hepatology (Baltimore, Md.). 935A-935A. 2009
  • HEDGEHOG-RELATED ACCUMULATION OF NKT CELLS PROMOTES FIBROGENESIS IN PROGRESSIVE NON ALCOHOLIC FATTY LIVER DISEASE.  Hepatology (Baltimore, Md.). 351A-351A. 2009
  • INCREASED DIETARY FRUCTOSE IMPAIRS HEPATIC ATP HOMEOSTASIS IN NAFLD.  Hepatology (Baltimore, Md.). 777A-777A. 2009
  • INTERACTION BETWEEN HEDGEHOG PATHWAY SIGNALING AND LEPTIN IN RAT HEPATIC STELLATE CELLS.  Hepatology (Baltimore, Md.). 828A-828A. 2009
  • INTERNATIONAL COLLABORATIVE WORK: A UNIFIED LIST OF DRUGS ASSOCIATED WITH HEPATOTOXICITY AND THE REPORTING FREQUENCY OF LIVER EVENTS IN THE WHO.  Hepatology (Baltimore, Md.). 425A-425A. 2009
  • LABORATORY EXPERIENCE OF USING DRIED BLOOD SPOT ASSAY TO DIAGNOSE POMPE DISEASE.  Muscle & Nerve. 708-709. 2009
  • NICOTINE INDUCES STEREOTYPIC FIBROGENIC CHANGES IN HUMAN PRIMARY HEPATIC STELLATE CELLS, VIA PI-3 AND P38 MAP KINASES, TRANSIDUCED THROUGH NICOTINIC ACETYLCHOLINE RECEPTORS, UPREGULATED IN HUMAN FIBROTIC NON-ALCOHOLIC STEATOHEPATITIS.  Hepatology (Baltimore, Md.). 825A-825A. 2009
  • NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS WITH QUANTITATIVE ACOUSTIC RADIATION FORCE METHODS.  Hepatology (Baltimore, Md.). 743A-744A. 2009
  • NOVEL ROLE FOR HEDGEHOG PATHWAY ACTIVATION IN THE PATHOGENESIS OF PRIMARY SCLEROSING CHOLANGITIS.  Hepatology (Baltimore, Md.). 995A-995A. 2009
  • PHYSICAL ACTIVITY RECOMMENDATIONS, EXERCISE INTENSITY, AND HISTOLOGICAL SEVERITY OF NONALCOHOLIC FATTY LIVER DISEASE.  Hepatology (Baltimore, Md.). 388A-388A. 2009
  • SERUM APOLIPOPROTEIN CIII LEVELS ARE INDEPENDENTLY ASSOCIATED WITH HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION.  Hepatology (Baltimore, Md.). 1052A-1052A. 2009
  • STIMULATION OF LIVER-RESIDENT, BUT NOT CIRCULATING PLASMACYTOID DENDRITIC CELLS WITH TOLL-LIKE RECEPTOR AGONISTS RESULTS IN HIGH LEVELS OF INTERFERON ALPHA SECRETION DURING CHRONIC HCV INFECTION.  Hepatology (Baltimore, Md.). 932A-933A. 2009
  • THE EMORY LIVER TRANSPLANT PROGRAM: EFFECTIVENESS OF A STRUCTURED COMPREHENSIVE QUALITY IMPROVEMENT INITIATIVE.  Hepatology (Baltimore, Md.). 651A-652A. 2009
  • TRANSIENT HEDGEHOG PATHWAY ACTIVATION AND ACCUMULATION OF HEDGEHOG-RESPONSIVE MYOFIBROBLASTS PRECEDE EXPANSION OF LIVER EPITHELIAL PROGENITORS AFTER ACUTE CARBON TETRACHLORIDE INJURY.  Hepatology (Baltimore, Md.). 822A-822A. 2009
  • A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS.  Hepatology (Baltimore, Md.). 431A-432A. 2008
  • A STUDY OF TELAPREVIR COMBINED WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN SUBJECTS WITH WELL-DOCUMENTED NON-RESPONSE OR RELAPSE AFTER PREVIOUS PEGINTERFERON-ALFA-2A AND RIBAVIRIN TREATMENT: INTERIM ANALYSIS.  Hepatology (Baltimore, Md.). 1135A-1136A. 2008
  • DO GROWTH FACTORS IMPROVE SVR IN CHRONIC HCV-GENOTYPE 1 PATIENTS TREATED WITH PEG-INTERFERON AND RIBAVIRIN?.  Hepatology (Baltimore, Md.). 402A-402A. 2008
  • EXOSOMES RELEASED BY HEPATIC STELLATE CELLS AND IMMATURE BILIARY EPITHELIAL CELLS CONTAIN BIOLOGICALLY-ACTIVE HEDGEHOG LIGANDS.  Hepatology (Baltimore, Md.). 407A-407A. 2008
  • GENDER-SPECIFIC ASSOCIATIONS BETWEEN REGIONAL ANTHROPOMETRIC MEASURES AND HEPATIC FIBROSIS IN PATIENTS WITH NAFLD.  Hepatology (Baltimore, Md.). 804A-804A. 2008
  • GENE EXPRESSION PROFILES COUPLED WITH SIGNATURES OF ONCOGENIC PATHWAY DYSREGULATION PROVIDE A RATIONAL APPROACH TO DISSECTING THE MOLECULAR HETEROGENEITY OF HEPATOCELLULAR CARCINOMA.  Hepatology (Baltimore, Md.). 1120A-1120A. 2008
  • HEDGEHOG ACTIVATES AND MODULATES HEPATIC INVARIANT NKT (INKT) RESPONSES.  Hepatology (Baltimore, Md.). 1001A-1001A. 2008
  • HEDGEHOG PATHWAY ACTIVATION PROMOTES HEPATIC FIBROSIS IN MICE WITH DIET-INDUCED NON-ALCOHOLIC STEATOHEPATITIS.  Hepatology (Baltimore, Md.). 828A-829A. 2008
  • HEMATOLOGIC SAFETY DATA FROM THE IDEAL TRIAL: NEUTROPENIA, ANEMIA AND THROMBOCYTOPENIA PROFILES OF PEGINTERFERON ALFA/RIBAVIRIN.  Hepatology (Baltimore, Md.). 1145A-1145A. 2008
  • HIGH PREDICTIVE ACCURACY OF AN UNBIASED PROTEOMIC PROFILE TO PREDICT SUSTAINED VIROLOGIC RESPONSE IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS.  Hepatology (Baltimore, Md.). 403A-403A. 2008
  • INTERIM RESULTS FROM A PHASE 1B DOSE-ESCALATION STUDY OF 4 WEEKS OF PEG-INTERFERON LAMBDA (PEG-RIL-29) TREATMENT IN SUBJECTS WITH HEPATITIS C VIRUS (HCV) GENOTYPE 1 WITH PRIOR VIROLOGIC RESPONSE AND RELAPSE TO PEGINTERFERON ALFA AND RIBAVIRIN.  Hepatology (Baltimore, Md.). 385A-385A. 2008
  • PARACRINE HEDGEHOG SIGNALING BETWEEN CHOLANGIOCYTES AND MYOFIBROBLASTS PROMOTES NKT CELL MIGRATION TOWARDS BILIARY EPITHELIAL CELLS: A NOVEL MECHANISM FOR NKT CELL ACCUMULATION IN PRIMARY BILIARY CIRRHOSIS.  Hepatology (Baltimore, Md.). 595A-596A. 2008
  • POSSIBLE MODULATION OF ACETAMINOPHEN-ASSOCIATED LIVER INJURY BY DIVERSE CO-MEDICATIONS IN THE AERS DATABASE - A QUANTITATIVE SIGNAL DETECTION ANALYSIS.  Hepatology (Baltimore, Md.). 471A-472A. 2008
  • PREDICTING THE ABILITY TO ACHIEVE A SUSTAINED VIROLOGIC RESPONSE (SVR) IN THE FIRST 12 WEEKS: RESULTS FROM THE IDEAL STUDY.  Hepatology (Baltimore, Md.). 1134A-1134A. 2008
  • PROGRESSIVE HEDGEHOG PATHWAY ACTIVATION ACCOMPANIES THE DUCTULAR REACTION DURING NAFLD PROGRESSION IN MICE AND HUMANS.  Hepatology (Baltimore, Md.). 829A-829A. 2008
  • PROPRANOLOL PROMOTES OVAL CELL ACCUMULATION BY ENHANCING HEPATOCYTE DEATH IN NON ALCOHOLIC STEATOHEPATITIS.  Hepatology (Baltimore, Md.). 831A-831A. 2008
  • SUSTAINED ACTIVATION OF RAC1 ENHANCES HEDGEHOG-MEDIATED EPITHELIAL-MESENCHYMAL TRANSITION IN CULTURED RAT HEPATIC STELLATE CELLS.  Hepatology (Baltimore, Md.). 380A-381A. 2008
  • SUSTAINED VIROLOGIC RESPONSE (SVR) AND PREDICTORS OF RESPONSE IN AFRICAN AMERICAN (AA) PATIENTS IN THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE 3B STUDY.  Hepatology (Baltimore, Md.). 430A-431A. 2008
  • THE EFFECT OF ONE YEAR OF INTENSIVE LIFESTYLE INTERVENTION ON HEPATIC STEATOSIS.  Hepatology (Baltimore, Md.). 812A-812A. 2008
  • THE PERFORMANCE OF THE AST TO PLATELET RATIO INDEX AS A NONINVASIVE MARKER OF FIBROSIS IN PEDIATRIC PATIENTS WITH CHRONIC VIRAL HEPATITIS.  Hepatology (Baltimore, Md.). 513A-513A. 2008
  • TREATMENT WEEK 24 RESULTS OF WEIGHT-BASED TARIBAVIRIN VERSUS WEIGHT-BASED RIBAVIRIN, BOTH WITH PEGINTERFERON ALFA-2B, IN NAiVE CHRONIC HEPATITIS C, GENOTYPE 1 PATIENTS.  Hepatology (Baltimore, Md.). 433A-434A. 2008
  • VIRAL RESPONSES IN AFRICAN-AMERICANS, LATINOS AND CAUCASIANS IN THE US PHASE 2 STUDY (PROVE1) OF TELAPREVIR WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAME GENOTYPE 1-INFECTED SUBJECTS WITH HEPATITIS C.  Hepatology (Baltimore, Md.). 1131A-1132A. 2008
  • DISTAL SYMMETRICAL MYOPATHY IN THE SETTING OF PEGYLATED INTERFERON ALFA AND RIBAVIRIN THERAPY FOLLOWING LIVER TRANSPLANTATION..  Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. S186-S186. 2008
  • Association of AST and ALT with liver histology in adults with NAFLD.  Hepatology (Baltimore, Md.). 738A-738A. 2007
  • Fructose induced hyperuricemia as a causal mechanism for nonalcoholic fatty liver disease.  Hepatology (Baltimore, Md.). 293A-293A. 2007
  • HIV entry and replication stellate cells promotes cellular activation and fibrogenesis: Implications for hepatic fibrosis in HIV/HCV co-infection.  Hepatology (Baltimore, Md.). 291A-291A. 2007
  • Hedgehog signaling and epithelial mesenchymal transitions during biliary fibrosis.  Hepatology (Baltimore, Md.). 336A-336A. 2007
  • Influence of impaired glucose tolerance, glucose control status, light to moderate alcohol consumption, and reduced carbohydrate diets on serum ALT change during rapid weight loss in the residential weight loss program.  Hepatology (Baltimore, Md.). 740A-740A. 2007
  • Pretransplant risk factors for advanced chronic kidney disease in liver transplantation.  Hepatology (Baltimore, Md.). 492A-492A. 2007
  • Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells.  Hepatology (Baltimore, Md.). 866A-867A. 2007
  • A novel model for harvesting adult liver progenitor cells.  Hepatology (Baltimore, Md.). 473A-473A. 2006
  • DGAT1 ASO treatment reduces hepatic fibrosis without improving hepatic steatosis in DB/DB mice fed methionine choline deficient diets.  Hepatology (Baltimore, Md.). 663A-663A. 2006
  • DGAT2 aso treatment improves hepatic steatosis, but not fibrosis in DB/DB mice fed methionine choline deficient diets.  Hepatology (Baltimore, Md.). 665A-665A. 2006
  • Influence of lifestyle factors and comorbidities on liver function in patients undergoing weight loss treatment.  Hepatology (Baltimore, Md.). 646A-646A. 2006
  • Lambert-Eaton myasthenic syndrome: Findings in 97 patients.  Muscle & Nerve. 543-543. 2006
  • Multifocal motor neuropathy with upper motor neuron signs.  Muscle & Nerve. 514-514. 2006
  • Muscle-specific kinase antibody myasthenia gravis: Response to treatment in 25 patients.  Muscle & Nerve. 542-543. 2006
  • Peroxisome proliferator-activated receptor gamma inhibits transforming growth factor beta-induced plasminogen activator inhibitor-1 expression in human stellate cells by interfering with Smad3 phosphorylation.  Hepatology (Baltimore, Md.). 690A-690A. 2006
  • Predictors of the development of de novo hepatocellular carcinoma (HCC) in patients awaiting orthotopic liver transplantation (OLT) during the meld era.  Hepatology (Baltimore, Md.). 506A-507A. 2006
  • The role of hepatitis C genotype 3 core protein domain 3 in intrahepatic steatosis.  Hepatology (Baltimore, Md.). 300A-300A. 2006
  • Conserved hedgehog pathway regulation of murine and human hepatic progenitors throughout life.  Hepatology (Baltimore, Md.). 740A-740A. 2005
  • Elevated CD4+/CD25+ regulatory T cell number and function in acute hepatitis C genotype 1, presage chronic evolution..  Hepatology (Baltimore, Md.). 541A-541A. 2005
  • Glucose-6-phosphate dehydrogenase deficiency is associated with severe anemia during interferon and ribavirin therapy.  Hepatology (Baltimore, Md.). 648A-648A. 2005
  • Hedgehog signaling in hepatic stellate cells from adult mice and rats.  Hepatology (Baltimore, Md.). 733A-733A. 2005
  • Histological acute alcoholic hepatitis does not impair survival after liver transplantation.  Hepatology (Baltimore, Md.). 494A-494A. 2005
  • IL-15 increases regenerative activity in the livers.  Hepatology (Baltimore, Md.). 572A-572A. 2005
  • Rac over-expression in activated hepatic stellate cells increases susceptibility to liver injury.  Hepatology (Baltimore, Md.). 267A-267A. 2005
  • Resolution of acute HBV infection is associated with a highest frequency and function of CD3+/CD4+/CD25+T cells..  Hepatology (Baltimore, Md.). 713A-713A. 2005
  • Aggressive recurrent HCV liver disease following liver transplantation in the absence of any immunosuppression..  Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. C76-C76. 2005
  • Isolated liver transplantation in infants with end stage liver disease due to short bowel syndrome..  Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. C22-C22. 2005
  • (Re)examining conformational constraint as a design strategy for protein-binding peptides.  Biopolymers. 536-537. 2005
  • (Re)examining conformational constraint as a design strategy for protein-binding peptides.  Biopolymers. 591-591. 2005
  • Novel technology for cost-effective expression and purification of recombinant proteins and peptides.  Biopolymers. 530-531. 2005
  • Novel technology for cost-effective expression and purification of recombinant proteins and peptides.  Biopolymers. 538-539. 2005
  • Structure based rational design of inhibitors of PDZ-containing molecular scaffolds.  Biopolymers. 591-591. 2005
  • Activation of embryonic developmental programs in non-alcoholic fatty liver disease.  Hepatology (Baltimore, Md.). 196A-196A. 2004
  • Dietary factors influence hepatic innate immune system and inflammation..  Hepatology (Baltimore, Md.). 285A-285A. 2004
  • Metronidazole: A newly recognized cause of autonomic neuropathy.  Muscle & Nerve. 522-522. 2004
  • Natural killer T cells regulate liver regeneration..  Hepatology (Baltimore, Md.). 182A-182A. 2004
  • Peripheral nerve ultrasound as an adjunct to electrodiagnostic testing.  Muscle & Nerve. 541-542. 2004
  • Design and thermodynamic binding studies of cyclic and multivalent peptide ligands for the PDZ domain.  Biopolymers. 297-298. 2003
  • Design and thermodynamic binding studies of cyclic and multivalent peptide ligands for the PDZ domain.  Biopolymers. 413-413. 2003
  • Doctor Who? A Study of Patient Provider Awareness.  Journal of Hospital Medicine.